# 바이오스페이스 일일 뉴스 리포트 - 2025년 09월 17일


## 주요 헤드라인

1. **Doctors Still Prescribing Sarepta’s DMD Gene Therapy After Safety Concerns (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/doctors-still-prescribing-sareptas-dmd-gene-therapy-after-safety-concerns>

2. **Doctors Still Prescribing Sarepta’s DMD Gene Therapy After Safety Concerns (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/doctors-still-prescribing-sareptas-dmd-gene-therapy-after-safety-concerns>

3. **Novo’s Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/novos-amylin-injectable-cagrilintide-hits-11-8-weight-reduction-in-phase-iii-trial>

4. **Novo’s Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/novos-amylin-injectable-cagrilintide-hits-11-8-weight-reduction-in-phase-iii-trial>

5. **Stealth, Barth Community Await FDA Verdict With ‘Everything at Stake’ (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/stealth-barth-community-await-fda-verdict-with-everything-at-stake>

6. **Stealth, Barth Community Await FDA Verdict With ‘Everything at Stake’ (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/stealth-barth-community-await-fda-verdict-with-everything-at-stake>

7. **Novo, Lilly Jostle For Market Lead in Obesity With New Regulatory Efforts (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/novo-lilly-jostle-for-market-lead-in-obesity-with-new-regulatory-efforts>


---
*2025년 09월 17일 바이오스페이스 뉴스 피드에서 생성된 리포트*